Depo SubQ Provera 104 offers a subcutaneous injection alternative to the traditional Depo-Provera intramuscular injection. This contraceptive, made by Pfizer, contains medroxyprogesterone acetate. It is administered every 12-14 weeks. Though marketed as a convenient birth control, the drug has high risk for brain tumor development.
Studies show that women who use contraceptives with medroxyprogesterone acetate, like Depo SubQ Provera 104, are at significant health risk. According to a recent study published in the British Medical Journal (BMJ) in March 2024, researchers found that women using these injections showed a 5.6-fold greater risk of developing meningioma compared to women who have never used such products.
Depo SubQ Provera 104 is a lower-dose alternative to Depo-Provera, but it still has the active ingredient linked to brain tumors. Regular injections of medroxyprogesterone acetate may raise the risk for intracranial meningioma. The risk grows with prolonged use.
Researchers have associated medroxyprogesterone acetate in Depo SubQ Provera 104 with severe neurological complications. Users of this medication may develop the following:
The product label lists common side effects, like irregular bleeding and weight gain but it does not warn enough about the risk of brain tumors.
If you got Depo SubQ Provera injections and developed meningioma, you may be owed compensation. So, please do not hesitate to contact us. We have over 35 years of experience helping victims of dangerous drugs. We can check if you are eligible to file a Depo SubQ Provera 104 claim.
We know a brain tumor diagnosis is very challenging. We will do our best to ease the legal process for you. We will check your case by phone as soon as possible. If you are eligible, we will connect you with an attorney who specializes in dangerous drug cases.